November 2020
Featured in a business monthly: "Tremendous Investment Opportunity in Biotechnology: Gene Editing Technology." ...
12 November, 2020
A synergistic combination of expertise in genomics, nanotechnology and microfluidics.
Unleashing the power of gene sequencing with 4th generation solid-state nanopore technology based on massively scalable IC manufacturing capability to advance the fields of medicine, science and engineering.
Genvida offers disruptive technologies for real time sequencing and strives to institute mass-market applications.
Latest News
-
-
10 May 2020
Covered in a business monthly: "Startup funding goes low key amidst COVID-19 and social unrest." ...
13 May, 2020 -
2 April 2020
Featured in a news article: "[Virus Decode] Hong Kong returnee from the US carrying out research on nanopore DNA sequencing to speed up viral diagnostic test."...
03 April, 2020
